TMCnet News
BioHeartland Indiana Debuts at BIO 2026, Showcasing Indiana's Global Bioscience LeadershipNew regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs. INDIANAPOLIS, June 22, 2026 /PRNewswire/ -- Today at BIO International Convention in San Diego, the CEOs of Indiana Corporate Partnership announced the bioscience sector across Indiana will now be known as "BioHeartland Indiana."
For more than a century, Indiana's life sciences ecosystem has been inventing, making and moving bioscience solutions at global scale across human health, animal health and plant science. The state's leading role in the GLP-1 revolution is a tangible example of what's possible when discovery, research, development, manufacturing and distribution exist within a single connected ecosystem. With Eli Lilly, Elanco Animal Health, and Corteva, the region is home to global leaders in human health, animal health, and plant science. The state's four R1 universities, the nation's largest medical school, and the Indiana Bioscience Research Institute, combined with the industry researchers, serve to generate 3x the national average for issued patents. The biosciences sector contributes over $100B of economic activity to the state. "Indiana is a powerhouse in human, animal and plant biosciences, but our story has not been told with the clarity, consistency or urgency it deserves," said Melina Kennedy, CEO of the CEOs of Indiana Corporate Partnership. "What makes this region different is not just that we make bioscience solutions, we are also a hotbed of invention and discovery, with the manufacturing strength, logistics infrastructure and collaborative spirit to move innovations into the world. BioHeartland gives us a shared identity to help investors, companies and talent understand the full value of what Indiana offers." The announcement follows Governor Mike Braun's $1 billion commitment to help Indiana's life sciences companies accelerate growth over the next ten years. "People will hear the words 'BioHeartland Indiana' and automatically think, "that's a place open for science and innovation where industry professionals across the entire value chain deliver solutions in a practical, collaborative way, enabling companies to move with speed from lab to market," said Vince Wong, president and CEO of BioCrossroads, a non-profit organization that grows, advances, and invests in Indiana's life sciences and healthcare sectors. "When it comes to biosciences, people will think of Indiana the same as Boston, the Research Triangle of North Carolina, or een international locations like Zurich and Basel." Indiana's bioscience industry currently generates more than $125 billion in annual economic impact and leads the nation in both life sciences and pharmaceutical exports. BIO International Convention Fifteen BioHeartland Indiana partners are attending BIO International including: Eli Lily and Company, Elanco Animal Health, 16 Tech Innovation District, One Health Innovation District, Genezen, Heartland BioWorks Tech Hub powered by the Applied Research Institute, Indiana Biosciences Research Institute, Indiana Economic Development Corporation, IU Launch Accelerator for Biosciences, Indiana Life Sciences Association, Indy Partnership, Langham Logistics and Purdue University. BioCrossroads is leading BioHeartland Indiana's presence at BIO International Convention. BioHeartland Indiana is located at Booth 3134 and will host a series of in-booth conversations designed to give BIO attendees a closer look at the people, places and capabilities behind Indiana's life sciences momentum. A schedule of events and details about BioHeartland's presence at BIO International can be found on the organization's website. About BioHeartland Indiana About CICP About AgriNovus Indiana About BioCrossroads Media Contact:
SOURCE BioHeartland Indiana 
|
View original content to download multimedia: